News

Combination therapy could expand treatment options for AML patients, extend survival

ESMO 2025: Research targets treatment resistance in neuroendocrine tumours

Disrupting cancer’s secret hubs: A new way to halt tumour growth

New insight in to role of immune system in colorectal cancer

Obesity-related cancer rising among both younger and older adults worldwide

ESMO 2025: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma

What is the extent of disparities in cancer clinical trials among low- and middle-income countries?

ESMO 2025: Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer

ESMO 2025: ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors

ESMO 2025: Drug combo cuts risk of death in advanced prostate cancer by 40%

ESMO 2025: New generation of antibody-drug conjugates shows promise in early-stage disease